ADEPT Test / CSAM Questions and A
m m m m m m
nswers (100% Pass) m m
Am50myearmoldmmalempresentsmtomamprimarymcaremclinicmwithmhismwife maftermamc
ompletionmofmthreemdayminpatientmadmissionmformtreatmentmofmalcoholmwithdr
awalmdisorder.mHemstatesmthatmhemfeltmverymdepressedmpriormtomhismadmissionma
ndmhe mstillmhasmsomemdepressionmandminsomniamsymptoms,mbutmthatmhemismfeeli
ngmbettermnow.mWhichmofmthemfollowingmismtruemregardingmthemtreatmentmofmpati
entsmwithmco-occurringmdepressionmandmalcoholmuse mdisorder?
Waitmform30mdaysmofmabstinencemfrommalcoholmbeforemevaluatingmformtreatment
m ofmdepression
Treatmentmofmdepressionmwithmconcurrentmalcoholmusemdisordermhavemnombenefit
Patient mismfeelingmbetter,msomnomneedmformevaluationmofmdepression
Depressionmwasmpartmofmalcoholmwithdrawalmsymptoms,mneedmtomcontinue mtomt
reatwithdrawalmsymptoms
Master01m |m October,m 2024/2025m |m Latestm update
, 1m|mP mamgme m m m m Grade m A+
Evaluatemformdepressionmatmadmissionmtomdetoxification,masmwellmasmatmthemtim
e mofmdischarge,regardlessmofmdaysmofmsobrietymdays
✓ Evaluat e mformdepressionmat madmission mtomdet oxification,masmwell masmat mt h
emtimemofm discharge, mregardlessm ofmdaysm ofm sobrietym days
✓m
✓ Evidencem hasmbeenmlimit edm onmt hem usemofm antidepressant m medicationsmin
patientsm withm co-
occuringmdepressionm andm alcoholm usem disorderm (AUD).m However, m met a-
analysism st udym hasm shown mthat m antidepressants mout performedmplacebomi
nmthemtreat ment mofm depressionminm patient sm with
AUDm(Iovineo).mAnothermst udymalsomshowedmthat mamongmpatientsmwithmdep
ressionmandmAUD,m thosemwhomweremnot mgivenm antidepressant m medicationm
at mthemtimemofmdischarge,m 100%mresumedm alcoholm useminm4m monthsm (Green
field).m Anotherm studym showedm that m medicationm treat ment mform depressionm
withmAUDmhasmsignificant mbenefit m(Nuens)m*mIovineo,
Antidepressant smformmajormdepressivemdisordermandmdyst hymicmdisordermi
nmpatient sm wit hm comorbidmAUD:
Amfirstmtimemusermofmoxycodone mreportsmamsuddenmrushmofmeuphoriamandmenerg
y.mWhichmofmthemfollowingmneurologicalmpathwaysmismprimarilymresponsiblemform
thismeffect?
Dorsalmraphe mnucleusmprojectionsmtomnucleusmaccumbens
Master01m |m October,m 2024/2025m |m Latestm update
, 1m|mP mamgme m m m m Grade m A+
Nucleusmaccumbensmprojectionsmtomventralmtegmentalmarea
Ventralmtegmentalmarea mprojectionsmtomdorsalmraphe mnucleus
Ventralmtegmentalmarea mprojectionsmtomnucleusmaccumbens
✓ Ventralmt egment al m aream projectionsmt omnucleusm accumbens
✓m
✓ Thempositive mreinforcingm effectsm ofm subst ancesm andm pleasurablem behavi
orsmduemto mdopaminergicm projectionsm from mt hem ventral mt egment al m area m
(VTA)mtomthe m nucleus m accumbens m(NAcc)mrepresents mthe m neural m mecha
nismmmost m consist entlymimplicat edminmt hem development m of
addiction, m especiallyminm earlym st ages.m The m NAcc m alongm wit hmt hem olfactory
m tubulemaremlocat ed minmthe mventral m striat um. mThe mdorsalmraphe mnucleus mis
ammidbrainmclust ermofmserot onergic mneurons, mwhichmmaymbemrelevant mfor m
m
themeffect smofm cert ainm subst ancesm such m asm hallucinogensm andm M DMA,m bu
t mismnot masm universallymimplicat edminm subst ance m andmbehavioral m positive
reinforcement.
Master01m |m October,m 2024/2025m |m Latestm update
, 1m|mP mamgme m m m m Grade m A+
1. Asmpartmofmamresearchmstudy,mvolunteersmwithmseveremopioidmusemdisord
ermreceivemmonetarymvouchersmformprovidingmopioid-
negativemurinemsamples.mWhichmofmthe mfollowingmbestmdescribesmthismbeh
avioralmtreatment mstrategy?
twelve-
stepmfacilitationmcontingenc
ymmanagementmcognitivembe
havioralmtherapymcommunit
ymreinforcement mmotivation
almenhancement
✓ contingencymmanagement
2. Am28-year-
oldmmalemismbroughtmtomthe mEDmbymhismroommatemformagitationmaftermamprolong
edmcocaine mbinge.mHismBP mism160/90mandmHRmism125.mThe mmostmappropriate m
medicationmwouldmbe:
IVmhaloperidol
m IVmlorazepa
mmIVmlabetalo
l
IVmchlorpromazine
m sublingualmclonidin